Transcriptomics Market Report 2025 (Global Edition)

Global Transcriptomics Market Report 2025 Market Size Split by Type (Consumables, Instruments, Software, Services), by Technology (Microarrays, q PCR, Sequencing Technology), by Application (Drug Disc...

Transcriptomics Market Report Description

We have various report editions of Transcriptomics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Transcriptomics Market Insights Video

Competitive Landscape of the Transcriptomics Market

The competitive landscape of the transcriptomics market is shaped by a mix of established players and emerging companies. These companies are involved in various aspects of transcriptomics, including technology development, sequencing services, bioinformatics, and diagnostics.

October 2023: The company, Centogene N.V., which is a vital life science partner for data-driven solutions in neurodegenerative and rare diseases, recently announced the addition of state-of-the-art transcriptome analysis to its MOx multiomic diagnostic platform. To give doctors the most comprehensive testing capacity, CENTOGENE's MOx 2.0 is a single-step multiomic solution that integrates DNA sequencing, biochemical testing, and now RNA sequencing. Source: https://www.centogene.com/news-events/news/newsdetails/centogene-expands-multiomic-diagnostic-portfolio-with-newly-launched-transcriptomic-offering.

 

Top Companies Market Share in Transcriptomics Industry: (In no particular order of Rank)

• Agilent Technologies Inc.
• Bio-Rad Laboratories
• F-Hoffmann La-Roche
• Fluidigm Corporation
• General Electric Company
• Illuminia Inc.
• Merck & Co. Inc
• Promega Corporation
• QiagenInc
• Thermofisher Scientific
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Transcriptomics Market

Which Region Dominates the Transcriptomics Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. The United States and other countries in North America are at the forefront of transcriptome technology development and application. The market's expansion is aided by the existence of significant players like 10x Genomics, Thermo Fisher Scientific, and Illumina. Furthermore, the area is home to several universities and research centers that are leaders in the field of transcriptomics. Numerous transcriptomic investigations are supported by funding from government organizations like the National Science Foundation (NSF) and the National Institutes of Health (NIH).

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Transcriptomics market. The biotechnology and pharmaceutical industries have grown significantly in nations like China, Japan, South Korea, and India. The need for transcriptome technologies in drug development, personalized medicine, and clinical diagnostics is largely driven by these industries. Asia Pacific nations are also increasing their research and development expenditures, especially in the fields of genomics and biological sciences. Transcriptomics is progressing due to government initiatives, academic collaborations, and corporate sector funding.

 

The current report Scope analyzes Transcriptomics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Transcriptomics Market Analysis

According to Cognitive Market Research, the global Transcriptomics market size was estimated at USD 5984.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2393.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Transcriptomics market with a market size of USD 1888.61 million in 2024 and is projected to grow at a CAGR of 5.9% during the forecast period. The demand is amplified by the nation's growing prevalence of chronic disease.
• The Canada Transcriptomics market had a market share of USD 287.24 million in 2024 and is projected to grow at a CAGR of 6.9% during the forecast period. Canada's growing investment.
• The Mexico Transcriptomics market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 217.82 million in 2024.

Europe Transcriptomics Market Analysis

According to Cognitive Market Research, the global Transcriptomics market size was estimated at USD 5984.2 Million out of which Europe held the market more than 30% of the global revenue with a market size of USD 1795.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

• The United Kingdom's Transcriptomics market had a market share of USD 301.60 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. In the UK, Transcriptomics sales witnessed an upswing due to the growing investment.
• The France Transcriptomics market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 165.16 million in 2024.
• According to Cognitive Market Research, the German Transcriptomics market size was valued at USD 355.46 million in 2024 and is projected to grow at a CAGR of 6.6% during the forecast period. In Germany, Transcriptomics sales surged due to the increasing technological advancements.
• The Italy Transcriptomics market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 154.39 million in 2024.
• The Russia Transcriptomics market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 278.27 million in 2024.
• The Spain Transcriptomics market is projected to witness growth at a CAGR of 5.5% during the forecast period with a market size of USD 147.21 million in 2024
• The Luxembourg Transcriptomics market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 55.65 million in 2024.
• The Portugal Transcriptomics market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 37.70 million in 2024.
• The Greece Transcriptomics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 21.54 million in 2024.
• Rest of Europe's Transcriptomics market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 278.27 million in 2024.

Asia Pacific Transcriptomics Market Analysis

According to Cognitive Market Research, the global Transcriptomics market size was estimated at USD 5984.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1376.37 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2031.

• According to Cognitive Market Research, China's Transcriptomics market size was valued at USD 619.36 million in 2024 and is projected to grow at a CAGR of 9.4% during the forecast period. Transcriptomics sales surged in China due to increasing technology advancements.
• The Japan Transcriptomics market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 189.94 million in 2024.
• The India Transcriptomics market had a market share of USD 165.16 million in 2024 and is projected to grow at a CAGR of 11.7% during the forecast period. India's growing investment in healthcare infrastructure.
• The South Korea Transcriptomics market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 137.64 million in 2024.
• The Australian Transcriptomics market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 71.57 million in 2024.
• The South East Asia Transcriptomics market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 94.97 million in 2024.
• The Rest of the Asia Pacific Transcriptomics market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 97.72 million in 2024.

South America Transcriptomics Market Analysis

According to Cognitive Market Research, the global Transcriptomics market size was estimated at USD 5984.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 299.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

• According to Cognitive Market Research, Brazil Transcriptomics market size was valued at USD 128.06 million in 2024 and is projected to grow at a CAGR of 7.9% during the forecast period. Transcriptomics sales flourish in Brazil due to rising technological advancement.
• Argentina Transcriptomics market had a market share of USD 50.27 million in 2024 and is projected to grow at a CAGR of 8.2% during the forecast period. The growing investment drives the market growth in the nation.
• Colombia Transcriptomics market is projected to witness growth at a CAGR of 7.1% during the forecast period with a market size of USD 26.63 million in 2024.
• Peru Transcriptomics market is projected to witness growth at a CAGR of 7.5% during the forecast period with a market size of USD 24.54 million in 2024.
• Chile Transcriptomics market is projected to witness growth at a CAGR of 7.6% during the forecast period with a market size of USD 21.54 million in 2024.
• The Rest of Latin America Transcriptomics market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 48.17 million in 2024.

Middle East Transcriptomics Market Analysis

According to Cognitive Market Research, the global Transcriptomics market size was estimated at USD 5984.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 119.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

• The GCC Countries Transcriptomics market is projected to witness growth at a CAGR of 8.4% during the forecast period with a market size of USD 51.22 million in 2024. Transcriptomics sales flourish due to growing technological advancement.
• The Egypt Transcriptomics market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 12.57 million in 2024.
• The South Africa Transcriptomics market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 18.91 million in 2024. Transcriptomics sales flourish in South Africa due to the rising investment.
• The Turkey Transcriptomics market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 10.29 million in 2024.
• The Nigeria Transcriptomics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 12.57 million in 2024.
• The Rest of MEA Transcriptomics market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 14.12 million in 2024.

Transcriptomics Market Analysis

Transcriptomics Market Type Segment Analysis

According to Cognitive Market Research, Consumables stand out as the dominating category. Consumables are essential to the transcriptomics industry since they help with every step of the process, from preparing samples to analyzing data. The segment's growth and competitiveness will be primarily driven by ongoing innovation, cost-effectiveness, and quality control.

Software emerged as the fastest-growing category in the Transcriptomics market. Transcriptomics software is in great demand due to the growing use of high-throughput sequencing technologies (such as RNA-Seq), an increase in research funding, and developments in computational biology. Transcriptomics software is becoming increasingly capable and useful due to ongoing algorithm development, machine learning techniques, and integration with multi-omics data.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Transcriptomics Industry. Request a Free Sample PDF!

Transcriptomics Market Technology Segment Analysis

According to Cognitive Market Research, the dominating category is Microarrays. Thousands of genes' expression levels can be simultaneously analyzed due to platforms called microarrays. They are made up of tiny areas of DNA probes that are affixed to a solid surface (such as a silicon chip or glass slide), each of which represents a distinct gene or RNA sequence.

The fastest-growing category in the Transcriptomics market is Sequencing Technology. The expansion of this category has been driven by recent technology improvements such as simultaneous extensive genome sequencing, greater sensitivity, complete genome coverage, and sample multiplexing. The use of next-generation sequencing (NGS) in genome research is growing. Researchers can increase the application of high-quality, low-cost genome sequencing in cell studies to comprehend transcriptome and genome architecture. Researchers could use improved sequencing platforms with long-read technology to produce reliable and reasonably priced sequence data.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Transcriptomics Application Segment Analysis

Application Segment Analysis

According to Cognitive Market Research, the dominating category is Drug Discovery. The discipline of transcriptomics, which encompasses single-cell RNA-sequencing (scRNA-seq) and high-plex imaging, offers major technological breakthroughs for the identification of novel therapeutics and biomarker detection in comparison to traditional RNA-sequencing methods. The market may expand as a result of the high throughput methods needed to find therapeutic targets and progress drug development. The growth of the market has also been aided by the introduction of novel techniques into clinical and pharmaceutical research, such as high-throughput RNA-sequencing and microarrays.

The fastest-growing category in the Transcriptomics market is Diagnostics and Disease Profiling. The segment expansion is attributed to the growing prevalence of chronic disease across the globe and ongoing technological advancements. Furthermore, the growing funding by private and public entities further drives the expansion of the market.

• Drug Discovery
• Diagnostics and Disease Profiling
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion